Clinical Trial Update: PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence [Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 2 colorectal cancer study comparing panitumumab rechallenge followed by regorafenib versus the reverse sequence; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)
• Stivarga (regorafenib)

Snippet

Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING